Neuro-Cardio-Autonomic Modulations in Children with Duchenne Muscular Dystrophy

被引:2
|
作者
Inbaraj, Ganagarajan [1 ]
Arjun, Krishnamurthy [2 ]
Meghana, Adoor [1 ]
Preethish-Kumar, Veeramani [3 ]
John, Anu P. [1 ]
Polavarapu, Kiran [3 ]
Nashi, Saraswati [3 ]
Sekar, Deepha [4 ]
Udupa, Kaviraja [1 ]
Prathuysha, Parthipulli, V [5 ]
Prasad, Krishna [1 ]
Bardhan, Mainak [3 ]
Raju, Trichur R. [1 ]
Kramer, Boris W. [6 ]
Nalini, Atchayaram [3 ]
Sathyaprabha, Talakad N. [1 ]
机构
[1] Natl Inst Mental Hlth & Neurosci, Dept Neurophysiol, Bangalore, Karnataka, India
[2] Dayananda Sagar Univ, Sch Engn, Dept CSE, Bangalore, Karnataka, India
[3] Natl Inst Mental Hlth & Neurosci, Dept Neurol, Bangalore, Karnataka, India
[4] Natl Inst Mental Hlth & Neurosci, Dept Mol Genet, Bangalore, Karnataka, India
[5] Natl Inst Mental Hlth & Neurosci, Dept Biostat, Bangalore, Karnataka, India
[6] Maastricht Univ, Sch Mental Hlth & Neurosci, Med Ctr, Dept Paediat, Maastricht, Netherlands
关键词
Duchenne muscular dystrophy; autonomic modulation; heart rate variability; blood pressure variability; baroreflex sensitivity; HEART-RATE-VARIABILITY; DYSFUNCTION; CARDIOMYOPATHY; INFLAMMATION; INDEXES; REFLEX;
D O I
10.3233/JND-221621
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Objective: Duchenne muscular dystrophy (DMD) is a degenerative X-linked muscle disease. Death frequently results from complications in cardiopulmonary systems. Preclinical/early diagnosis of cardiac autonomic abnormalities may aid initiate cardioprotective therapy and enhance prognosis. Methods: A cross sectional, prospective study of 38 DMD boys compared with 37 age-matched healthy controls was conducted. Lead II electrocardiography and beat-to-beat blood pressure were recorded to assess heart rate variability (HRV), blood pressure variability (BPV), and baroreceptor sensitivity (BRS) in a standardized environment. Data were analysed and correlated with disease severity and genotype.Results: In the DMD group, the median age at assessment was 8 years [IQR 7-9 years], the median age at disease onset was 3 years [IQR, 2-6 years], and the mean duration of illness was 4 years [IQR, 2.5-5]. DNA sequencing showed deletions in 34/38 (89.5 %) and duplications in 4/38 (10.5%) patients. The median heart rate in DMD children was significantly higher [101.19 (Range, 94.71-108.49)] /min compared to controls [81 (Range, 76.2-92.76)] /min (p < 0.05). All the assessed HRV and BPV parameters were significantly impaired in DMD cases except for the coefficient of variance of systolic blood pressure. Further, BRS parameters were also significantly reduced in DMD, excluding alpha-LF. A positive correlation was found between alpha HF with age at onset and duration of illness. Conclusion: This study demonstrates a distinct early impairment of neuro-cardio-autonomic regulation in DMD. Simple yet effective non-invasive techniques such as HRV, BPV, and BRS may help identify cardiac dysfunction in a pre-clinical state, paving the way for early cardio-protective therapies and limiting disease progression in DMD patients.
引用
收藏
页码:227 / 238
页数:12
相关论文
共 50 条
  • [31] Duchenne muscular dystrophy
    Biggar, WD
    PEDIATRICS IN REVIEW, 2006, 27 (03) : 83 - 88
  • [32] Duchenne muscular dystrophy
    Paula Ronchetti, Maria
    Slavsky, Anahi
    Leal, Julieta
    Diaz, Sofia
    Belen Alonso, Maria
    Garrido, Jessica
    Kessler, Karina
    Selandari, Jorge
    ARCHIVOS ARGENTINOS DE PEDIATRIA, 2011, 109 (05): : 453 - U1506
  • [33] Duchenne muscular dystrophy
    不详
    VETERINARY RECORD, 2009, 165 (06) : 161 - 161
  • [34] Duchenne muscular dystrophy
    McDonald, Craig M.
    Abresch, Richard T.
    Carter, Gregory T.
    Fowler, William M. Jr.
    Johnson, E. Ralph
    Kilmer, David D.
    Sigford, Barbara J.
    American Journal of Physical Medicine & Rehabilitation, 1995, 74 (Suppl)
  • [35] Duchenne muscular dystrophy
    Dongsheng Duan
    Nathalie Goemans
    Shin’ichi Takeda
    Eugenio Mercuri
    Annemieke Aartsma-Rus
    Nature Reviews Disease Primers, 7
  • [36] Duchenne muscular dystrophy
    Susan T. Iannaccone
    Zohair Nanjiani
    Current Treatment Options in Neurology, 2001, 3 (2) : 105 - 117
  • [37] Duchenne muscular dystrophy
    Lankester, Benedict J. A.
    Whitehouse, Michael R.
    Gargan, Martin F.
    CURRENT ORTHOPAEDICS, 2007, 21 (04): : 298 - 300
  • [38] Duchenne muscular dystrophy
    Chamberlain, Jeffrey S.
    CURRENT OPINION IN GENETICS & DEVELOPMENT, 1991, 1 (01) : 11 - 14
  • [39] Seated Outcome Measures in Children With Duchenne Muscular Dystrophy
    Kern, Rebecca
    Carvell, Kimberly
    Gupta, Apeksha
    Verma, Sumit
    PEDIATRIC PHYSICAL THERAPY, 2022, 34 (03) : 375 - 380
  • [40] Is Molecular Diagnosis Necessary for Children with Duchenne Muscular Dystrophy?
    Puri, Ratna Dua
    INDIAN PEDIATRICS, 2019, 56 (07) : 549 - 550